Custom Antibody Market: By Service (Antibody Development), Source (Mice, Others), Research Area (Oncology, Neurobiology), Type (Monoclonal Antibodies, Polyclonal Antibodies), End Users (Biotechnology Companies) — Forecast till 2027

Custom Antibody Market Scenario:
The Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period (2018–2023).

Custom antibody provides high specificity and selectivity, these antibodies are easy to produce as compared to other antibodies and are hence the preferred choice in all types of research studies. Factors such as increasing research activity in life sciences industry along with increasing associations between industry and academic centers is driving the growth of the custom antibody market. The advantage of custom antibody is that it accomplishes well in a qualitative or quantitative immunodetection method. The quality of catalog antibodies is also an area of concern in this market, and henceforth end users prefer custom-made antibodies.

Segmentation:
The Custom Antibody Market has been segmented on the basis of service, source, type, research area and end users.

On the basis of service, the market has been classified as antibody development, antibody production & purification, antibody fragmentation & labeling. The antibody development is segmented in to antibody characterization, antigen preparation, immunization & hybridoma production.

On the basis of source, the market has been classified as mice, rabbits, human beings and others.

On the basis of type, the market has been classified as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, others.

On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, other research areas

On the basis of end users, the market has been classified as pharmaceutical & biotechnology companies, hospitals and clinics, academic & research institutes, contract research organizations.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European custom antibody market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The custom antibody market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The custom antibody market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Custom Antibody Market Share, by Region, 2017 (%)

Source: MRFR Analysis

In the custom antibody market, North America is anticipated to account for largest market share due to the early adoption of advanced medical technologies, continuous development by companies operating into disease treatment. The largest market share is credited to the increasing focus of researchers on high-quality antibodies for reproducibility, which can be hampered by using commercially available antibodies.
The European market is expected to hold the second largest market share. Factors such as a rise in research expenses, advancement of technology, the decline in human health, and the necessity for innovative and effective therapies boost the growth of the market in this region. According to Capra Science, a European company specialized in custom antibody production, llama-derived nanobodies might find therapeutic application in Parkinson’s disease.

Whereas the Asia-Pacific region is projected to be the fastest growing segment experience in the near future due to the growing therapeutic industry in India and China, also the increasing funds in life science research by the government organizations of these countries are aspects driving the growth of the Asia-Pacific market. Similarly, the increasing research in genomics and proteomics, growing investments by pharmaceutical companies, rising awareness about personalized therapeutics, and growing research activities in the field of mAb-based therapeutics are boosting the growth of this custom antibody market in Asia-Pacific region.

The market in the Middle East & Africa is expected to account for the smallest share of the global custom antibody market due to an underdeveloped healthcare sector, the dearth of technical knowledge, and poor medical facilities.

Key Players:
Some of the key players in the global custom antibody market are Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab.

Custom Antibody Market, by Service:

• Antibody Development
  
  
  
  • Antibody Characterization
  
  
  • Antigen Preparation
  
  
  • Immunization & Hybridoma Production
  
  
  
  


• Antibody Production & Purification


• Antibody Fragmentation & Labeling

Custom Antibody Market, by Source:

• Mice


• Rabbits


• Human Beings


• Others

Custom Antibody Market, by Type:

• Monoclonal Antibodies


• Polyclonal Antibodies


• Recombinant Antibodies


• Other Custom Antibodies

Custom Antibody Market, by Research Area:

• Oncology


• Infectious Diseases


• Immunology


• Neurobiology


• Stem Cells


• Cardiovascular Diseases


• Others

Custom Antibody Market, by End-Users:

• Hospitals and Clinics


• Pharmaceutical & Biotechnology Companies


• Academic & Research Institutes


• Contract Research Organizations

Custom Antibody Market, by Region:

• Americas
  
  
  
  • North America
    
    
    
    • US
    
    
    • Canada
    
    
    
    
  
  
  • South America
  
  
  
  


• Europe
  
  
  
  • Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • UK
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Company Profiles:

• Thermo Fisher Scientific Inc.


• Genscript


• Abcam PLC


• Merck Group


• Bio-Rad Laboratories, Inc.


• Cell Signaling Technology, Inc.


• Agilent Technologies, Inc.


• Biolegend, Inc.


• Rockland Immunochemicals Inc.


• Promab Biotechnologies, Inc.


• Proteogenix


• Innovagen Ab

Intended Audience:

• Manufacturers and distributors


• Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)


• Research institutes


• Contract manufacturing organizations (CMOs)


• Government associations


• Market research and consulting firms


• Venture capitalists and investors